Posted by Michael Wonder on 10 May 2017
New safety risks detected in one-third of FDA approved drugs
9 May 2017 - Almost a third of drugs cleared by the Food and Drug Administration pose safety risks that are identified only after their approval, according to a study published Tuesday.
The researchers said the study, which appeared in JAMA, shows the need for ongoing monitoring of new treatments years after they hit the market.
“We seem to have decided as a society that we want drugs reviewed faster,” said lead author Joseph Ross, an associate professor of medicine and public health at Yale University. That makes it critically important “that we have a strong system in place to continually evaluate drugs and to communicate new safety concerns quickly and effectively,” he said.
